An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

In Taiwan, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs), gefitinib, erlotinib, and afatinib are served as first-line therapy for non-small lung cell cancer (NSCLC) patients with EGFR sensitizing mutations. However, the majority of patients who initially respond to E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Wu, Shang-Gin, Chiang, Chi-Lu, Liu, Chien-Ying, Wang, Chin-Chou, Su, Po-Lan, Hsia, Te-Chun, Shih, Jin-Yuan, Chang, Gee-Chen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498675/
https://ncbi.nlm.nih.gov/pubmed/33014788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01481
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados